AU2015330645B2 - Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis - Google Patents
Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis Download PDFInfo
- Publication number
- AU2015330645B2 AU2015330645B2 AU2015330645A AU2015330645A AU2015330645B2 AU 2015330645 B2 AU2015330645 B2 AU 2015330645B2 AU 2015330645 A AU2015330645 A AU 2015330645A AU 2015330645 A AU2015330645 A AU 2015330645A AU 2015330645 B2 AU2015330645 B2 AU 2015330645B2
- Authority
- AU
- Australia
- Prior art keywords
- osteoporosis
- alkyl
- bone
- compound
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 *c1cccc(CC(O)=O)c1 Chemical compound *c1cccc(CC(O)=O)c1 0.000 description 1
- CAERSDJFKGMKLY-UHFFFAOYSA-N CCOC(Cc1cc(Br)ccc1)=O Chemical compound CCOC(Cc1cc(Br)ccc1)=O CAERSDJFKGMKLY-UHFFFAOYSA-N 0.000 description 1
- XDOIIYQCWBRFOY-UHFFFAOYSA-N COC(Cc1cc(Br)cc(Br)c1O)=O Chemical compound COC(Cc1cc(Br)cc(Br)c1O)=O XDOIIYQCWBRFOY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/32—Phenylacetic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462062597P | 2014-10-10 | 2014-10-10 | |
| US62/062,597 | 2014-10-10 | ||
| PCT/CA2015/000540 WO2016054728A1 (en) | 2014-10-10 | 2015-10-08 | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2015330645A1 AU2015330645A1 (en) | 2017-05-04 |
| AU2015330645B2 true AU2015330645B2 (en) | 2020-03-12 |
Family
ID=55652429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015330645A Ceased AU2015330645B2 (en) | 2014-10-10 | 2015-10-08 | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20180228750A1 (enExample) |
| EP (1) | EP3203999B1 (enExample) |
| JP (1) | JP6700639B2 (enExample) |
| KR (1) | KR20170066476A (enExample) |
| CN (1) | CN106999456B (enExample) |
| AR (1) | AR102246A1 (enExample) |
| AU (1) | AU2015330645B2 (enExample) |
| BR (1) | BR112017007426A2 (enExample) |
| CA (1) | CA2963354A1 (enExample) |
| DK (1) | DK3203999T3 (enExample) |
| ES (1) | ES2785317T3 (enExample) |
| IL (1) | IL251404B (enExample) |
| MX (1) | MX376873B (enExample) |
| MY (1) | MY194308A (enExample) |
| PH (1) | PH12017500638A1 (enExample) |
| PL (1) | PL3203999T3 (enExample) |
| PT (1) | PT3203999T (enExample) |
| RU (1) | RU2709205C2 (enExample) |
| SG (1) | SG11201702868VA (enExample) |
| TW (1) | TWI699200B (enExample) |
| UY (1) | UY36356A (enExample) |
| WO (1) | WO2016054728A1 (enExample) |
| ZA (1) | ZA201702639B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016054725A1 (en) * | 2014-10-10 | 2016-04-14 | Prometic Biosciences Inc. | Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis |
| AU2015345943B2 (en) * | 2014-11-12 | 2020-03-19 | Liminal Biosciences Limited | Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration |
| CN107683135A (zh) | 2015-03-09 | 2018-02-09 | 因特克林医疗有限公司 | 用于治疗非酒精性脂肪肝疾病和/或脂肪营养不良的方法 |
| KR20190065252A (ko) * | 2016-08-18 | 2019-06-11 | 인테크린 테라퓨틱스, 아이엔씨. | 골 질환 치료용 PPARγ 작용제 |
| AU2018249822A1 (en) | 2017-04-03 | 2019-10-31 | Coherus Biosciences Inc. | PPArgamma agonist for treatment of progressive supranuclear palsy |
| AU2021356346A1 (en) * | 2020-10-06 | 2023-06-15 | Pharmaceutique Ingenew Inc. | Substituted aromatic compounds and pharmaceutical compositions thereof |
| MX2024005982A (es) * | 2021-11-17 | 2024-05-30 | Natreon Inc | Withania somnifera y asparagus racemosus en el tratamiento de enfermedades posmenopausicas. |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010127448A1 (en) * | 2009-05-04 | 2010-11-11 | Prometic Biosciences Inc. | Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof |
| WO2010127440A1 (en) * | 2009-05-04 | 2010-11-11 | Prometic Biosciences Inc. | Substituted aromatic compounds and pharmaceutical uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200720256A (en) * | 2005-05-13 | 2007-06-01 | Synta Pharmaceuticals Corp | IL-12 modulatory compounds |
| PH12013500763B1 (en) * | 2010-10-27 | 2018-07-04 | Prometic Pharma Smt Ltd | Phenylketone carboxylate compounds and pharmaceutical uses thereof |
| CN105997967B (zh) * | 2010-10-27 | 2019-08-23 | 普罗米蒂克医药Smt有限公司 | 用于治疗癌症的化合物和组合物 |
| TWI742541B (zh) * | 2013-03-15 | 2021-10-11 | 英商邊緣生物科技有限公司 | 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物 |
| TWI689490B (zh) * | 2013-03-15 | 2020-04-01 | 英商邊緣生物科技有限公司 | 用於治療纖維化之經取代之芳族化合物及相關方法 |
| WO2016054725A1 (en) * | 2014-10-10 | 2016-04-14 | Prometic Biosciences Inc. | Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis |
-
2015
- 2015-10-08 PL PL15849675T patent/PL3203999T3/pl unknown
- 2015-10-08 EP EP15849675.2A patent/EP3203999B1/en active Active
- 2015-10-08 JP JP2017518905A patent/JP6700639B2/ja not_active Expired - Fee Related
- 2015-10-08 WO PCT/CA2015/000540 patent/WO2016054728A1/en not_active Ceased
- 2015-10-08 TW TW104133254A patent/TWI699200B/zh not_active IP Right Cessation
- 2015-10-08 MX MX2017004733A patent/MX376873B/es active IP Right Grant
- 2015-10-08 KR KR1020177011332A patent/KR20170066476A/ko not_active Ceased
- 2015-10-08 RU RU2017116178A patent/RU2709205C2/ru active
- 2015-10-08 PT PT158496752T patent/PT3203999T/pt unknown
- 2015-10-08 AU AU2015330645A patent/AU2015330645B2/en not_active Ceased
- 2015-10-08 SG SG11201702868VA patent/SG11201702868VA/en unknown
- 2015-10-08 DK DK15849675.2T patent/DK3203999T3/da active
- 2015-10-08 CA CA2963354A patent/CA2963354A1/en not_active Abandoned
- 2015-10-08 BR BR112017007426-5A patent/BR112017007426A2/pt not_active Application Discontinuation
- 2015-10-08 CN CN201580058623.7A patent/CN106999456B/zh not_active Expired - Fee Related
- 2015-10-08 US US15/516,643 patent/US20180228750A1/en not_active Abandoned
- 2015-10-08 MY MYPI2017000520A patent/MY194308A/en unknown
- 2015-10-08 ES ES15849675T patent/ES2785317T3/es active Active
- 2015-10-13 UY UY0001036356A patent/UY36356A/es not_active Application Discontinuation
- 2015-10-13 AR ARP150103294A patent/AR102246A1/es unknown
-
2017
- 2017-03-27 IL IL251404A patent/IL251404B/en active IP Right Grant
- 2017-04-06 PH PH12017500638A patent/PH12017500638A1/en unknown
- 2017-04-12 ZA ZA2017/02639A patent/ZA201702639B/en unknown
-
2020
- 2020-04-09 US US16/844,813 patent/US11185521B2/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010127448A1 (en) * | 2009-05-04 | 2010-11-11 | Prometic Biosciences Inc. | Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof |
| WO2010127440A1 (en) * | 2009-05-04 | 2010-11-11 | Prometic Biosciences Inc. | Substituted aromatic compounds and pharmaceutical uses thereof |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11185521B2 (en) | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis | |
| EP2632452B1 (en) | Compounds and compositions for the treatment of cancer | |
| AU2014231649B2 (en) | Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis | |
| BR112020013694A2 (pt) | derivados de ácido 3-fenil-4-hexinôico como agonistas gpr40 | |
| AU2015330642B2 (en) | Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis | |
| HK1236420B (en) | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis | |
| HK1236420A1 (en) | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis | |
| HK1236419B (en) | Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis | |
| HK1236419A1 (en) | Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis | |
| JP2005035895A (ja) | 高カルシウム血症および骨疾患治療剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HB | Alteration of name in register |
Owner name: PROMETIC PHARMA SMT LIMITED Free format text: FORMER NAME(S): PROMETIC PHARMA SMT LIMITED |
|
| HB | Alteration of name in register |
Owner name: LIMINAL BIOSCIENCES LIMITED Free format text: FORMER NAME(S): PROMETIC PHARMA SMT LIMITED |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| HB | Alteration of name in register |
Owner name: LIMINAL BIOSCIENCES LIMITED Free format text: FORMER NAME(S): LIMINAL BIOSCIENCES LIMITED |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |